Real-world Experience of Abrocitinib on Difficult-to-treat Hand Eczema in Chinese Patients

被引:2
|
作者
Li, Yiting [1 ]
Tan, Xi [1 ]
Nie, Shu [1 ]
Tian, Xin [2 ,3 ]
Wu, Zhouwei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Dermatol, 100 Haining Rd, Shanghai 200080, Peoples R China
[2] Guangzhou Med Univ, Inst Dermatol, Guangzhou, Peoples R China
[3] Guangzhou Inst Dermatol, Dept Dermatol, 56 Hengfu Rd, Guangzhou 510095, Peoples R China
关键词
D O I
10.2340/actadv.v104.39822
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Real-world effectiveness of abrocitinib treatment in patients with difficult-to-treat atopic dermatitis
    Olydam, J. I.
    Schloesser, A. R.
    Custurone, P.
    Nijsten, T. E. C.
    Hijnen, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : 2537 - 2542
  • [2] Difficult-to-Treat Spondyloarthritis in Morocco: A Real-World Study
    Zemrani, Salma
    Amine, Bouchra
    ElBnoune, Imane
    Rostom, Samira
    Bahiri, Rachid
    MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, 2024, 35
  • [3] DIFFICULT-TO-TREAT, SPONDYLOARTHRITIS IN A REAL-WORLD MULTICENTRIC COHORT
    Gavi, M. B. R. O.
    Resende, G. G.
    Saad, C. G. S.
    Marques, C. D. L.
    Diniz, V. G.
    Golebiovski, R. T. M.
    Oliveira, T. L.
    Lage, R. C.
    Malheiro, O. B.
    Marinho, A. O.
    Galdino, I. M.
    Ribeiro, S. L. E.
    Bulbol, G. A.
    Paiva, B. E.
    Ochtrop, M. L. G.
    Menin, R. C.
    Soares, A. M.
    Ranzolin, A.
    Cavalcanti, N. G.
    Carneiro, J. N.
    Castro, G. R. W.
    Fernandes, J. M. C.
    Yazbek, M. A.
    Vieira, R. M. R. A.
    Souza, E. C. R.
    Pinheiro, M. M.
    Sampaio-Barros, P. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 60 - 61
  • [4] Abrocitinib for difficult-to-treat atopic dermatitis
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (12) : 546 - 546
  • [5] Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience
    Cacciapuoti, Sara
    Potestio, Luca
    Lucia, Gallo
    Letizia, Musumeci Maria
    Caldarola, Giacomo
    D'Amico, Domenico
    Francesco, Caudullo
    Valeria, Papaianni
    De Simone, Clara
    Peris, Ketty
    Megna, Matteo
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [6] Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experience
    Ronda, Mar
    Perez-Recio, Sandra
    Gonzalez Laguna, Monica
    Tubau Quintano, Maria de la Fe
    Llop Talaveron, Josep
    Soldevila-Boixader, Laura
    Carratala, Jordi
    Cuervo, Guillermo
    Padulles, Ariadna
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (07) : 932 - 939
  • [7] Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohort
    Schloesser, Anne R.
    Boeijink, Neill
    Olydam, Jill
    Nijsten, Tamar E. C.
    Hijnen, Dirkjan
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : 384 - 392
  • [8] Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors
    Alp, G.
    Kara, M.
    Cinakli, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2025, 43 (01) : 41 - 47
  • [9] UPADACITINIB TREATMENT IN A REAL-WORLD DIFFICULT-TO-TREAT ATOPIC DERMATITIS PATIENT COHORT
    Schlosser, Anne Rosalie
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 29 - 29
  • [10] Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study
    Philippoteaux, Cecile
    Delepine, Thibaut
    Cailliau, Emeline
    Philippe, Peggy
    Taisne, Nicolas
    Pascart, Tristan
    Cortet, Bernard
    Paccou, Julien
    Flipo, Rene-Marc
    Letarouilly, Jean-Guillaume
    JOINT BONE SPINE, 2024, 91 (02)